搜索临床试验以:BGB-A317
总计1286个结果
-
Mayo ClinicMultiple Myeloma Research Foundation完全的
-
Hospital for Special Surgery, New York完全的
-
Mayo ClinicNational Cancer Institute (NCI)主动,不招人
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI); Janssen Scientific Affairs, LLC撤销
-
Ohio State University Comprehensive Cancer CenterCelgene完全的
-
Therapeutic Advances in Childhood Leukemia Consortium终止
-
Merck Sharp & Dohme LLC完全的
-
Tibotec Pharmaceuticals, Ireland撤销
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)招聘中
-
Mayo Clinic主动,不招人
-
Mayo ClinicNational Cancer Institute (NCI)终止
-
Therapeutic Advances in Childhood Leukemia Consortium终止
-
Yazeed Sawalha招聘中弥漫性大 B 细胞淋巴瘤 | 转化为弥漫性大 B 细胞淋巴瘤的滤泡性淋巴瘤 | 转化为弥漫性大 B 细胞淋巴瘤的边缘区淋巴瘤美国
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)撤销
-
Roswell Park Cancer InstituteBristol-Myers Squibb主动,不招人
-
National Cancer Institute (NCI)主动,不招人
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
Mayo ClinicNational Cancer Institute (NCI)主动,不招人
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)主动,不招人
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)主动,不招人
-
National Cancer Institute (NCI)完全的宫颈腺癌 | 宫颈腺鳞癌 | 宫颈鳞状细胞癌,未另行说明 | IVA 期宫颈癌 AJCC v6 和 v7 | 复发性宫颈癌 | IV 期宫颈癌 AJCC v6 和 v7 | IVB 期宫颈癌 AJCC v6 和 v7美国
-
City of Hope Medical CenterNational Cancer Institute (NCI)尚未招聘
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)主动,不招人
-
Southwest Oncology GroupNational Cancer Institute (NCI)撤销IVA 期肺癌 AJCC v8 | IVB 期肺癌 AJCC v8 | 复发性肺癌 | IV 期肺癌 AJCC v8 | 肺鳞状细胞癌
-
University of Southern CaliforniaNational Cancer Institute (NCI)招聘中
-
Children's Cancer Group, ChinaXiangya Hospital of Central South University; Qilu Hospital of Shandong University; Ruijin Hospital 和其他合作者招聘中
-
Federal Research Institute of Pediatric Hematology...招聘中
-
Northwestern UniversityNational Cancer Institute (NCI); Ipsen Biopharmaceuticals完全的复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 铂类耐药输卵管癌 | 铂类耐药原发性腹膜癌 | 铂类耐药卵巢癌 | 难治性卵巢癌 | 难治性输卵管癌 | 难治性原发性腹膜癌美国
-
M.D. Anderson Cancer Center招聘中IB 期肝细胞癌 AJCC v8 | II 期肝细胞癌 AJCC v8 | 可切除的肝细胞癌 | I 期肝细胞癌 AJCC v8 | IA 期肝细胞癌 AJCC v8美国
-
M.D. Anderson Cancer CenterTakeda主动,不招人
-
Hospital for Special Surgery, New York完全的
-
Medical University of Lodz招聘中
-
Emory UniversityNational Cancer Institute (NCI)尚未招聘
-
M.D. Anderson Cancer CenterJazz Pharmaceuticals终止
-
National Cancer Institute (NCI)完全的Trebananib 联合或不联合 Bevacizumab、Pazopanib Hydrochloride、Sorafenib Tosylate 或 Sunitinib Malate 治疗晚期肾癌患者晚期肾细胞癌 | III 期肾细胞癌 AJCC v7 | IV 期肾细胞癌 AJCC v7 | 晚期肉瘤样肾细胞癌美国
-
University of LeedsMerck Sharp & Dohme LLC; Celgene; Amgen未知
-
Rashmi Verma, MDNational Cancer Institute (NCI)招聘中
-
University of Rochester NCORP Research BaseNational Cancer Institute (NCI)完全的